Ann Allergy Asthma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biologics for Severe Asthma Present Opportunities for Pharmacists

Drug therapy workups may reveal candidates for immune therapy and provide chance for interventions.

United statesUnited kingdomBenralizumab fasenraOmalizumab xolairRegeneron sanofiMepolizumab nucalaReslizumab cinqairDupilumab dupixentTeva respiratoryGlobal asthma initiativeGlobal initiative for asthmaMost recent national asthma dataPrevention programExpert panelGenentech incNational asthma education

More data needed on impact of intranasal corticosteroids on COVID-19 outcomes

More data needed on impact of intranasal corticosteroids on COVID-19 outcomes
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United kingdomKristen dowdByisabella hornickUniversity of stAndrews school of medicineHernandez santiagoAnn allergy asthma

Food Allergy Is Another Looming Epidemic

Contrary to earlier advice, new research suggests introducing infants to potential allergens early may reduce risk of developing allergies to those foods

Pediatr annOmalizumab xolairLigelizumab novartisJeannettey wickOffice of pharmacy professional developmentCommittee on nutritionUniversity of connecticutRisk evaluationManagement strategyPharmacy professional developmentAllergy clinAnn allergy asthma

Black, Asian, Hispanic Populations Have Higher Food Allergy Burden Compared to Non-Hispanic Whites

Future studies of socioeconomic factors and environmental elements contributing may help to further explain the causes of food allergies and inform targeted interventions and management.

United statesRuchis guptaNational opinion research centerNorthwestern universityFeinberg school of medicine ruchis guptaUniversity of chicagoFeinberg schoolFood allergyAsthma researchHispanic whiteHispanic blackSocioeconomic differencesFood allergiesAnn allergy asthma

U S FDA Approves Takeda s TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older

U S FDA Approves Takeda s TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAnthony castaldoJulie kimJun saitoErin marie bealsUs hereditary angioedema associationDrug administrationInternational mediaTakeda pharmaceutical companyTakeda pharmaceuticalsExchange commissionTakeda pharmaceutical company limitedOnly prophylaxis treatment approvedEfficacy data fromWith additional data fromPediatric patients